A study of the metabolism of methamphetamine and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in isolated rat hepatocytes.
T Kanamori, K Tsujikawa, Y Ohmae, Y T Iwata, H Inoue, T Kishi, T Nakahama, Y Inouye
文献索引:Forensic Sci. Int. 148(2-3) , 131-7, (2005)
全文:HTML全文
摘要
The metabolism of methamphetamine (MA) and 4-bromo-2,5-dimethoxyphenethylamine (2C-B) in freshly isolated rat hepatocytes was investigated, and compared with in vivo results. A suspended hepatocyte culture, established from male Wistar rats using a collagenase perfusion technique, was incubated in the presence of MA or 2C-B. After enzymatic hydrolysis of the conjugated forms, the metabolites were extracted by liquid-liquid partition and analyzed by gas chromatography/mass spectrometry (GC/MS). Amphetamine, p-hydroxymethamphetamine and p-hydroxyamphetamine were detected in the culture fluids of the rat hepatocytes inoculated with MA. The alcohol derivative, carboxylic acid derivative, 2-O-desmethyl-2C-B, 2-O-desmethyl-N-acetyl-2C-B and 5-O-desmethyl-N-acetyl-2C-B were detected in the case of 2C-B. The major metabolite of MA in rat hepatocytes was p-hydroxymethamphetamine. This is in good agreement with the urinary excretion profile for rats that were fed MA. 2-O-Desmethyl-2C-B and the carboxylic acid derivative were the major recovered metabolites of 2C-B in the rat hepatocyte culture, a slight deviation from the in vivo findings, in which 5-O-desmethyl-N-acetyl-2C-B was found to be the main component. Metabolites with a hydroxy group were largely present in their conjugated forms in the culture fluids, except for 2-O-desmethyl-2C-B. Taking these results into consideration, a primary hepatocyte culture system has the potential to provide a quick and handy method for estimating the in vivo metabolic fate of abused drugs.
相关化合物
相关文献:
1998-01-01
[J. Anal. Toxicol. 22(1) , 55-60, (1998)]
2006-01-01
[Xenobiotica 36(2-3) , 259-67, (2006)]
2003-04-23
[Forensic Sci. Int. 133(1-2) , 101-6, (2003)]
2012-07-01
[J. Forensic Sci. 57(4) , 1008-13, (2012)]
1997-07-01
[Biopharm. Drug Dispos. 18(5) , 423-32, (1997)]